Wells Fargo will downgrade Bausch + Lomb with intraocular lens recall on Thursday
Wells Fargo downgraded its stock Bausch + ROM To rating equal weights from overweight in Thursday’s notes.
At the same time, analyst Larry Biegelsen reduced the stock price target from $24 to $15. Bausch + Lomb shares closed at $15 on Thursday, with over 4% slipping during the day’s session after announcing a recall of envista intraocular lenses for potential safety concerns as the number of reports of toxic anterior segment syndrome increased.
BLCO 5D Chart
Biegelsen cited this recall as the main catalyst for downgrades. “Envista is an important growth driver, and the main entry for BLCO was an entry into the fast-growing premium IOL segment,” he writes.
Analysts added that they believe Envista products will eventually return to the market, but it is still unclear how long it will take for the issue to be resolved. He also predicted that the product would likely lose market share.
“Envista is stepping into the BLCO sidelines as he remembers his limited visibility on the impact/timeline, further complicating the outlook and likely to constrain the range of BLCO stocks,” the analyst wrote.
– Lisa Kailai Han
CoreWeave prices IPOs at $40 per share
Second consecutive week of stock
The main average has been paced with profits for the second week in a row. At the end of Thursday, here is where they stand:
– Salamine
Federal Reserve’s priority inflation measures are scheduled for Friday
According to an economist voted by Dow Jones, the Personal Consumption Expense Price Index for February rose 0.3% last month, and is expected to rise 2.5% from 12 months ago.
PCE Price Index readings are scheduled for Friday morning.
– Salamine
The probability of a V-shaped recovery after April 2nd is “very high,” says Tomley of Fundstrut.
Stocks were able to make a massive comeback after April 2, as investors last made clear in 2018 on the tariff front from President Donald Trump.
“The chances of a V-shaped recovery of stock coming after April 2 is very high because we have already adhered to many of the panic people saw in 2018,” Lee said Thursday of CNBC’s “Closing Bell: Overtime.”
In that case, Lee expects the epic seven stocks to be able to outperform. As an example, he focused on his recent recovery. Teslawhich has risen almost 10% this week after CEO Elon Musk was under pressure this year due to his involvement in the Department of Government Efficiency (DOGE). Electric vehicle inventory is still down 32% in 2025.
“If Tesla has led us to this balance, I think it’s a bold case that Mag Seven will become a group that will own in the coming months,” Lee said.
– Salamine
Stocks that make the most of the move after business hours
The stocks that make the biggest moves in expansion trading are:
Lululemon – Even if fourth quarter revenue and revenues surpassed analyst expectations, stocks fell 10% after athlete companies issued a quarter outlook that exceeded expectations. Lululemon forecasts first quarter revenues in the range of $2.53 to $2.58 per share compared to the $2.72 expected by analysts voted by LSEG. First quarter revenues were between $2.335 billion and $2.355 billion, lower than the consensus estimate of $2.39 billion.
Brazing – Stocks skyrocketed about 9% after the customer engagement platform posted fourth quarter results in which analysts’ expectations. Braze recorded adjusted earnings of 12 cents per share, surpassing the fact set consensus estimate of earnings of 5 cents per share. Additionally, revenues of $160.4 million exceeded $155.7 million, as predicted by analysts voted by FactSet.
– Salamine
